Protective effect of nicotinamide adenine dinucleotide (NAD+) against spinal cord ischemia–reperfusion injury via reducing oxidative stress-induced neuronal apoptosis

Journal of Clinical Neuroscience

Volumn 36, Issue , 2017, Pages 114-119

  Xie, Lei ^a   Wang, Zhenfei ^a   Li, Changwei ^a   Yang, Kai ^a   Liang, Yu ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Apoptosis; NAD+; Neurological deficits; Oxidative stress

Indexed keywords

APOPTOSIS INDUCING FACTOR; CASPASE 3; MALONALDEHYDE; NICOTINAMIDE ADENINE DINUCLEOTIDE; SUPEROXIDE DISMUTASE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BASSO BEATTIE BRESNAHAN SCORE; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME DEGRADATION; MALE; MOTOR PERFORMANCE; NERVE CELL NECROSIS; NERVOUS SYSTEM FUNCTION; NEUROLOGIC DISEASE ASSESSMENT; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SCORING SYSTEM; SPINAL CORD ISCHEMIA; TUNEL ASSAY; ANIMAL; DRUG EFFECTS; METABOLISM; NERVE CELL; SPRAGUE DAWLEY RAT;

ANIMALS; APOPTOSIS; MALE; NAD; NEURONS; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; SPINAL CORD ISCHEMIA;

EID: 85007200935     PISSN: 09675868     EISSN: 15322653     Source Type: Journal    
DOI: 10.1016/j.jocn.2016.10.038     Document Type: Article

References (36)

1. [1] Perez-Pinzon, M.A., Dave, K.R., Raval, A.P., Role of reactive oxygen species and protein kinase C in ischemic tolerance in the brain. Antioxid Redox Signal 7 (2005), 1150–1157.
2. [2] Conrad, M.F., Ye, J.Y., Chung, T.K., et al. Spinal cord complications after thoracic aortic surgery: long-term survival and functional status varies with deficit severity. J Vasc Surg 48 (2008), 47–53.
3. [3] Greenberg, R.K., Lu, Q., Roselli, E.E., et al. Contemporary analysis of descending thoracic and thoracoabdominal aneurysm repair: a comparison of endovascular and open techniques. Circulation 118 (2008), 808–817.
4. [4] de Haan, P., Kalkman, C.J., Jacobs, M.J., Pharmacologic neuroprotection in experimental spinal cord ischemia: a systematic review. J Neurosurg Anesthesiol 13 (2001), 3–12.
5. [5] Chen, H., Wang, Y., Zhang, J., et al. NAD(+)-carrying mesoporous silica nanoparticles can prevent oxidative stress-induced energy failures of both rodent astrocytes and PC12 cells. PLoS One, 8, 2013, e74100.
6. [6] Radak, D., Resanovic, I., Isenovic, E.R., Link between oxidative stress and acute brain ischemia. Angiology 65 (2014), 667–676.
7. + metabolism in health and disease. Trends Biochem Sci 32 (2007), 12–19.
8. + metabolism and NAD(+)-dependent enzymes: promising therapeutic targets for neurological diseases. Curr Drug Targets 13 (2012), 222–229.
9. + and NADH in cellular functions and cell death. Front Biosci 11 (2006), 3129–3148.
10. [10] Wang, Y., Kim, N.S., Haince, J.F., et al. Poly(ADP-ribose) (PAR) binding to apoptosis-inducing factor is critical for PAR polymerase-1-dependent cell death (parthanatos). Sci Signal, 4, 2011, ra20.
11. [11] Yu, S.W., Wang, H., Poitras, M.F., et al. Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science (New York, NY) 297 (2002), 259–263.
12. [12] Kauppinen, T.M., Swanson, R.A., The role of poly(ADP-ribose) polymerase-1 in CNS disease. Neuroscience 145 (2007), 1267–1272.
13. [13] Endres, M., Wang, Z.Q., Namura, S., et al. Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase. J Cereb Blood Flow Metab 17 (1997), 1143–1151.
14. + depletion and mitochondrial permeability transition. J Biol Chem 279 (2004), 18895–18902.
15. [15] Zhang, B., Gensel, J.C., Is neuroinflammation in the injured spinal cord different than in the brain? Examining intrinsic differences between the brain and spinal cord. Exp Neurol 258 (2014), 112–120.
16. [16] Zheng, C., Han, J., Xia, W., et al. NAD(+) administration decreases ischemic brain damage partially by blocking autophagy in a mouse model of brain ischemia. Neurosci Lett 512 (2012), 67–71.
17. [17] Usul, H., Cakir, E., Cobanoglu, U., et al. The effects of tyrphostine Ag 556 on experimental spinal cord ischemia reperfusion injury. Surg Neurol 61 (2004), 45–54.
18. [18] Basso, D.M., Beattie, M.S., Bresnahan, J.C., A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 12 (1995), 1–21.
19. [19] Schmidley, J.W., Free radicals in central nervous system ischemia. Stroke 21 (1990), 1086–1090.
20. [20] Diaz-Ruiz, A., Rios, C., Duarte, I., et al. Lipid peroxidation inhibition in spinal cord injury: cyclosporin-A vs methylprednisolone. NeuroReport 11 (2000), 1765–1767.
21. [21] Ildan, F., Polat, S., Oner, A., et al. Effects of naloxone on sodium- and potassium-activated and magnesium-dependent adenosine-5′-triphosphatase activity and lipid peroxidation and early ultrastructural findings after experimental spinal cord injury. Neurosurgery 36 (1995), 797–805.
22. [22] Varija, D., Kumar, K.P., Reddy, K.P., et al. Prolonged constriction of sciatic nerve affecting oxidative stressors & antioxidant enzymes in rat. Indian J Med Res 129 (2009), 587–592.
23. [23] Sas, K., Robotka, H., Toldi, J., et al. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders. J Neurol Sci 257 (2007), 221–239.
24. [24] Mattson, M.P., Culmsee, C., Yu, Z.F., Apoptotic and antiapoptotic mechanisms in stroke. Cell Tissue Res 301 (2000), 173–187.
25. [25] Yuan, J., Yankner, B.A., Apoptosis in the nervous system. Nature 407 (2000), 802–809.
26. [26] Nicholson, D.W., Ali, A., Thornberry, N.A., et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376 (1995), 37–43.
27. [27] Sasaki, Y., Araki, T., Milbrandt, J., Stimulation of nicotinamide adenine dinucleotide biosynthetic pathways delays axonal degeneration after axotomy. J Neurosci 26 (2006), 8484–8491.
28. [28] Wang, S., Xing, Z., Vosler, P.S., et al. Cellular NAD replenishment confers marked neuroprotection against ischemic cell death: role of enhanced DNA repair. Stroke 39 (2008), 2587–2595.
29. [29] Susin, S.A., Lorenzo, H.K., Zamzami, N., et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397 (1999), 441–446.
30. [30] Choudhury, S., Bae, S., Ke, Q., et al. Mitochondria to nucleus translocation of AIF in mice lacking Hsp70 during ischemia/reperfusion. Basic Res Cardiol 106 (2011), 397–407.
31. [31] Zhou, M., Baudry, M., EUK-207, a superoxide dismutase/catalase mimetic, is neuroprotective against oxygen/glucose deprivation-induced neuronal death in cultured hippocampal slices. Brain Res 1247 (2009), 28–37.
32. [32] Yamamoto, T., Byun, J., Zhai, P., et al. Nicotinamide mononucleotide, an intermediate of NAD+ synthesis, protects the heart from ischemia and reperfusion. Oxid Med Cell Longevity, 9, 2014, e98972, 10.1371/journal.pone.0098972.
33. [33] Hsu, C.P., Oka, S., Shao, D., et al. Nicotinamide phosphoribosyltransferase regulates cell survival through NAD+ synthesis in cardiac myocytes. Circ Res 105 (2009), 481–491.
34. [34] Andrabi, S.A., Kim, N.S., Yu, S.W., et al. Poly(ADP-ribose) (PAR) polymer is a death signal. Proc Natl Acad Sci USA 103 (2006), 18308–18313.
35. [35] Alano, C.C., Garnier, P., Ying, W., et al. NAD+ depletion is necessary and sufficient for poly(ADP-ribose) polymerase-1-mediated neuronal death. J Neurosci 30 (2010), 2967–2978.
36. [36] Rossi, F., Perale, G., Papa, S., et al. Current options for drug delivery to the spinal cord. Expert Opin Drug Deliv 10 (2013), 385–396.